Anomaly vs Waystar (2026)
Both attack denials with prediction and they sit at different points in the pipeline. Anomaly is upstream and specialised: its engine learns payer specific behaviour from hundreds of millions of transactions and predicts the payment amount and denial reason on a claim line in real time before submission, which is the only moment when a denial is still cheap to prevent. Waystar's intelligence suite sits on a broad revenue cycle platform many organisations already run, so the capability arrives inside an existing workflow rather than as another vendor. The choice is mostly about whether you want the sharpest instrument or fewer of them. The question both should answer and neither does is what happens when the framing most likely to be paid is not the most accurate one, because a model trained on what payers accept will find that boundary whether or not anyone intended it.
- It works before submission rather than after denial, predicting the payment amount and the denial reason on the claim line in real time so the claim can be fixed while it can still be fixed.
- The prediction is genuinely learned against payer behaviour rather than rules based, adapting as payers change rules rather than waiting for someone to update an edit.
- The published precision figure is quantified with unusual honesty about what it does and does not cover, which is rare in this segment.
- The AltitudeAI suite sits on top of a revenue cycle platform an organisation may already run, so the prediction arrives inside the workflow rather than as another system.
- Breadth across the revenue cycle means one vendor covers eligibility, claims, denials and payments rather than the prediction step alone.
- For a health system standardising on a single revenue cycle vendor, an added intelligence layer is a smaller change than inserting a specialist upstream.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Anomaly and Waystar are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Anomaly | Waystar |
|---|---|---|
| Primary category | RCM & Prior Auth AI | RCM & Prior Auth AI |
| Founded | 2020 | Not recorded |
| Headquarters | New York, New York, United States | Louisville, Kentucky |
| Website | findanomaly.com | waystar.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Anomaly its top capability grade on AI Centrality. Set against Waystar, Anomaly grades higher on AI Centrality and Autonomy and Oversight Model. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Waystar its top capability grade on several axes, including HIPAA and BAA Posture, Security Certifications and Trust Center and FDA and Regulatory Status. Set against Anomaly, Waystar grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Anomaly or Waystar?
On the axes where the AI Health Index separates them, Anomaly grades higher on AI Centrality and Autonomy and Oversight Model, and Waystar grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Waystar leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Anomaly and Waystar differ most?
The widest separation the AI Health Index records between Anomaly and Waystar is on AI Centrality, where Anomaly grades A and Waystar grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Anomaly and Waystar grade the same?
The AI Health Index grades Anomaly and Waystar the same on Clinical and Operational Evidence, AI Governance and Bias Disclosure and AI Liability and Recourse. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
Prediction against payer behaviour raises a question neither vendor addresses: a model that learns which claims get paid will also learn which framings get paid, and the line between correcting an error before submission and optimising a claim toward what a payer will accept is not one either company draws publicly. Ask both what the system does when the highest paying framing is not the most accurate one.
Anomaly publishes no security attestation, health privacy statement, business associate terms, retention position or training use statement, which is a wide gap for a platform processing claims data at very large volume. Neither publishes pricing.